Search
for
Sort by
Research 30 of 1000+
- Long-Term Suppression of Testosterone After Treatment with a Gonadotropin-Releasing Hormone Agonist in a Woman with a Presumed Testosterone Secreting Ovarian Tumor
- Sequential estrogen-progestin addition to gonadotropin-releasing hormone agonist suppression for the chronic treatment of ovarian hyperandrogenism: a pilot study.
- Differential Suppression of Testosterone and Estradiol in Hirsute Women With the Superactive Gonadotropin-Releasing Hormone Agonist Leuprolide*
- Hyperandrogenic eumenorrheic NON-PCOS women versus women with PCOS after the GnRH-agonist stimulation test preceded by suppression of adrenal steroidogenesis with dexamethasone
- Spontaneous fertility in a male patient with testotoxicosis despite suppression of FSH levels
- Cross‐Sex Hormone Therapy in Trans Persons Is Safe and Effective at Short‐Time Follow‐Up: Results from the European Network for the Investigation of Gender Incongruence
- Oral Contraceptives: Their Mode of Action and Dermatologic Applications
- The Case of the Elusive Androgen
- Ovarian hyperthecosis in adolescent females: two case reports and a review of the literature
- Ovarian hyperthecosis coexisting with an incidental adrenal lesion: challenges in the diagnostic approach
- Treatment of androgen excess in females: Yesterday, today and tomorrow
- Recent advances in the treatment of polycystic ovary syndrome
- The hyperandrogenic-insulin-resistant acanthosis nigricans syndrome: therapeutic response
- Clinical and Hormonal Effects of Chronic Gonadotropin Releasing Hormone Agonist Treatment in Polycystic Ovarian Disease*
- Postmenopausal Hyperandrogenism in a Patient With an Adrenal Adenoma: How Should We Approach It?
- Utilisation of gonadotrophin-releasing hormone (GnRH) analogue to differentiate ovarian from adrenal hyperandrogenism in postmenopausal women
- Treatment of Hirsutism with a Gonadotropin-Releasing Hormone Agonist (Nafarelin)∗
- The Role of Oral Contraceptives in the Treatment of Hyperandrogenic Disorders
- The Evaluation and Management of Hirsutism
- Clinical Utility of GnRH Analogues in Female Androgen Excess: Highlighting Diagnostic and Therapeutic Applications
- PHARMACOLOGICAL BASIS FOR CLINICAL USE OF ANTIANDROGENS
- Impact of Cyproterone Acetate and Ethinylestradiol on Clomiphene Resistant PCOS Patient with High Serum AMH level
- The treatment of polycystic ovary syndrome.
- Prostate-Sparing Effects in Primates of the Potent Androgen 7α-Methyl-19-Nortestosterone: A Potential Alternative to Testosterone for Androgen Replacement and Male Contraception1
- 17-Hydroxyprogesterone Responses to Gonadotropin-Releasing Hormone Disclose Distinct Phenotypes of Functional Ovarian Hyperandrogenism and Polycystic Ovary Syndrome
- Gonadotrophin-releasing hormone agonist therapy for hirsutism is as effective as high dose cyproterone acetate but results in a longer remission
- Effect of finasteride, a 5 alpha-reductase inhibitor, on serum gonadotropins in normal men.
- Role of Environmental Factors and Gonadotoxin Exposure in Unexplained Male Infertility
- Telogen Effluvium Secondary to Weight Loss and Therapy With Chorionic Gonadotropin
- DIAGNOSTIC AND THERAPEUTIC UTILITY OF GONADOTROPHIN-RELEASING HORMONE AGONIST IN POSTMENOPAUSAL HYPERANDROGENISM OF OVARIAN ORIGIN